Equine Healthcare Market Outlook 2028

1. Equine Healthcare Market Outlook 2028 The globalequine healthcare market was valued at US$698.7 Mn in 2020 It is estimated to expand at a CAGR of 4.3% from 2021 to 2028 The global equine healthcare marketisexpected to cross the value of US$972.8 Mn by the end of 2028    Analysts’ Viewpoint on Equine Healthcare Market Scenario Equine practitioners are practicing strict biosecurity at all farms, performance venues, racetracks, and the likes during the ongoing COVID-19 pandemic. It has been found that issues of recurring common horse healthcare problems are affecting market growth. Hence, stakeholders in the equine healthcare market should increase awareness about regular de-worming schedules and professional veterinary advice to reduce the incidence of recurring common horse healthcare problems. Therapeutics such as corticosteroids are being extensively used as joint injections. Bisphosphonates such as tiludronate disodium (Tildren) and clondronate (Osphos) are labelled for controlling clinical signs associated with navicular syndrome. There is a need for research surrounding bisphosphonate use in horses under the age of four. Comprehensive Equine Vaccine Portfolio Creates Revenue Opportunities for Manufacturers Equine practitioners are performing a risk-benefit analysis to determine if a horse should receive a particular risk-based vaccine. This is necessary since extra vaccinations can be costly and can cause unnecessary stress to the horse. Manufacturers in the equine healthcare market are increasing the production of vaccines to improve clinical numbers. With the help of risk-benefit analysis, veterinarians are educating horse owners about different types of risk-based vaccines such as equine influenza and strangles vaccines for horses active at events. Manufacturers in the equine healthcare market are developing the anthrax vaccine for horses that live in an area where spores are known to thrive in the soil. On the other hand, pregnant mares during specific months of pregnancy are advised to receive certain risk-based vaccines. Companies are developing a diverse portfolio in vaccine such as the equine herpesvirus, botulism and rotaviral diarrhea. Request https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1603 Sample: AVMA Draws Guidance for Equine Veterinarians amid Ongoing COVID-19 Pandemic

2. Apart from ensuring healthcare services for horses, the COVID-19 pandemic has drawn attention to the wellbeing of equine veterinarians. Stakeholders in the equine healthcare market are taking cues from the AVMA (American Veterinary Medical Association) such as following the hierarchy of controls to reduce the spread of the novel infection among equine practitioners. While PPE (personal protective equipment) serves as an important protective function, the optimal way to prevent disease transmission is to use a combination of interventions from across the hierarchy of controls. Participants in the equine healthcare market are re-scheduling non-urgent veterinary procedures. They are considering telemedicine as an alternative to in-person visit. Professional Veterinary Intervention Helps Overcome Recurring Common Horse healthcare Problems Common horse healthcare problems such as laminitis or thrush can leave a horse more likely to contract it again. Hence, participants in the market are educating horse owners to seek professional veterinary advice and veterinary intervention to improve clinical outcomes. The high prevalence of allergies, colic, and mud fever, among other common horse healthcare problems, is triggering the demand for healthcare services. Such findings are contributing to the growth of the equine healthcare market. Problems of worms, sweet itch and back problems are translating into revenue opportunities for market stakeholders. Enquiry https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=160 3 Before Buying: Wearables Enable Early Indication of healthcare Issues in Horses Apart from drugs, vaccines and supplemental feed additives, market stakeholders are boosting R&D in the equestrian sports technology such as wearables for horses. As such, there is a need for validated approaches of consistently and regularly tracking healthcare parameters such as temperature, heart rate, and respiratory rates. Thus, wearable devices hold promising potentials to offer these statistics. The data gathered by wearable devices has the ability to give an earlier indication of issues, which may require veterinary investigation. Such innovations are translating into incremental opportunities for med-tech companies in the equine healthcare market.

3. Safety and Welfare of Horses Crucial While Innovating in Therapeutics In the racing industry, medication use has changed drastically over the years, as manufacturers develop new drugs whilst scientists hone techniques they use to analyze and identify therapeutic medications. healthcare companies are focusing on maintaining a level playing field, protecting the safety of the horse, and protecting the betting public. As such, companies are boosting the production of corticosteroids, NSAIDs, and bisphosphonates, among other drugs. Racing regulators have historically permitted NSAID use within 24-hrs of race time. However, in the recent times, there have been recommendations to increase the timeframe to no earlier than 48-hrs. Equine Healthcare Market: Overview According to Transparency Market Research’s latest report on the global equine healthcare market for the historical period 2017–2019 and forecast period 2021–2028, strong impact of the equine industry on the economy is projected to drive the global equine healthcare market during the forecast period  Strong Impact of Equine Industry on Economy: Key Driver The equine industry involves breeding, keeping, and overall management of horses. It has a strong impact on the overall economy. The industry creates income opportunities for several veterinary physicians, equestrians, and others. Additionally, it involves a supply demand scenario of equine healthcare products. Strong economic impact of the equine industry is expected to drive the global equine healthcare market.  Request https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1603 Brochure: High Incidence of Equine Infections: Major Driver Horse breeding is a core activity in the equine industry. Hence, choice of breeding stock and better healthcare management of breeds are crucial to improve breeding operations. Occurrence of equine infections is another major concern for the breeders. For instance, South America and the Caribbean have high incidence of Potomac horse fever.  The West Nile Virus infection among horses has been controlled; however, sudden emergence of the virus can cause concerns among horse owners. Moreover, tetanus and 

4. equine influenza cases are evident among the global horse community. Hence, high incidence of equine infections is likely to drive the global equine healthcare market. Decline in Global Equine Population to Hamper Market The global equine healthcare market has strong correlation with the global equine population  According to a research, the horse population in the Americas declined by 5.37% in the past five years, while the horse population declined by 7.47% during the same period  Hence, fall in the global horse population is likely to restrain the global equine healthcare market during the forecast period  Equine Healthcare Market: Competition Landscape This report profiles major players in the global equine healthcare market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments  The global equine healthcare market is highly fragmented, with the presence of a number of international as well as regional players  Leading players operating in the global equine healthcare market are  oBayer AG (Bayer Animal healthcare) oBoehringer Ingelheim oCeva Santé Animale oEli Lilly and Company (Elanco) oEquine Products UK Ltd. oMerck & Co. (Merck Animal healthcare) oSanofi (Merial) oPurina Animal Nutrition LLC. oVetoquinol S.A. oZoetis Equine Healthcare Market: Key Developments Key players in the global equine healthcare market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global equine healthcare market. A few expansion strategies adopted by players operating in the global equine healthcare market are:  oMerck & Co. (Merck Animal healthcare) is committed to bringing the latest technologies to the research efforts. The company focuses on advancing veterinary

5. medicine through novel solutions in key therapeutic areas. Acquisition of Vallée S.A would make Merck & Co. a renowned player in Brazil, and thereby in Latin America in the near future. Merck & Co. is likely to gain market share in Latin America during the forecast period. oBayer Animal healthcare is a global leader in animal healthcare and helps farmers, veterinarians, and pet owners by offering innovative products. The company develops and commercializes vaccines, drugs, and other products for companion and farm animals. The products reduce the risk of transmission of pathogens from animals to humans. It has expanded business globally and has strong presence in North America and Europe. Its primary manufacturing units are in Germany and the U.S. About Transparency Market Research Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End- Use that will favor growth in the market over the next 9 years. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030

6. USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email:sales@transparencymarketresearch.com